PDF(Pubmed)
Abstract：
BACKGROUND: Recent advancements in and the proliferation of autonomous mobility technology, such as intelligent wheelchairs, have made it possible to provide mobility services for patients with reduced mobility due to musculoskeletal disorders. In the present study, we conducted a preliminary clinical study to assess the safety and feasibility of in-hospital autonomous transportation using a driverless mobility (wheelchair) for patients with musculoskeletal disorders.
METHODS: From January to February 2022, 51 patients with musculoskeletal disorders exhibiting gait disturbance who presented to our institution were included in the present study. Driverless mobility rides were conducted over a straight-line distance of 100 m from the orthopaedic outpatient reception to the payment counter after the outpatient consultation. We assessed the quality of life using an EQ-5D-5 L index and pain using a VAS score before riding the mobility to investigate the patient\'s condition. After the ride, a questionnaire survey was conducted to assess patient satisfaction on a 5-point scale. In addition, adverse events during the mobility ride were investigated.
RESULTS: Overall satisfaction levels showed that 44 out of 51 (86%) patients rated the level as 3 or higher. There were no significant differences in the level of satisfaction based on the cause of disorders or EQ-5D-5 L Index. Among 19 patients who rated the level of satisfaction as 2-3, the ratio of postoperative patients and those with pain tended to be higher (p < 0.05). While 26 of 51 (51%) patients reported moments of feeling unsafe during the mobility ride, no actual adverse events, such as collisions, were observed.
CONCLUSIONS: An in-hospital autonomous transportation service using a driverless mobility for patients with musculoskeletal disorders demonstrated high satisfaction levels and was safe with no severe adverse events observed. The expansion of autonomous mobility deployment is expected to achieve mobility as a service in medical care.
METHODS: From January to February 2022, 51 patients with musculoskeletal disorders exhibiting gait disturbance who presented to our institution were included in the present study. Driverless mobility rides were conducted over a straight-line distance of 100 m from the orthopaedic outpatient reception to the payment counter after the outpatient consultation. We assessed the quality of life using an EQ-5D-5 L index and pain using a VAS score before riding the mobility to investigate the patient\'s condition. After the ride, a questionnaire survey was conducted to assess patient satisfaction on a 5-point scale. In addition, adverse events during the mobility ride were investigated.
RESULTS: Overall satisfaction levels showed that 44 out of 51 (86%) patients rated the level as 3 or higher. There were no significant differences in the level of satisfaction based on the cause of disorders or EQ-5D-5 L Index. Among 19 patients who rated the level of satisfaction as 2-3, the ratio of postoperative patients and those with pain tended to be higher (p < 0.05). While 26 of 51 (51%) patients reported moments of feeling unsafe during the mobility ride, no actual adverse events, such as collisions, were observed.
CONCLUSIONS: An in-hospital autonomous transportation service using a driverless mobility for patients with musculoskeletal disorders demonstrated high satisfaction levels and was safe with no severe adverse events observed. The expansion of autonomous mobility deployment is expected to achieve mobility as a service in medical care.
摘要：
背景：自主移动技术的最新进展和扩散，比如智能轮椅，有可能为因肌肉骨骼疾病而行动不便的患者提供行动不便的服务。在本研究中,我们进行了一项初步临床研究,以评估肌肉骨骼疾患患者使用无人驾驶移动设备(轮椅)进行院内自主运输的安全性和可行性.
方法：从2022年1月至2月，51例出现步态障碍的肌肉骨骼疾病患者被纳入本研究。在门诊咨询后，从骨科门诊接待处到付款柜台的直线距离为100m，进行了无人驾驶出行。我们使用EQ-5D-5L指数评估生活质量，并在骑行活动前使用VAS评分评估疼痛，以调查患者的病情。骑行之后,我们进行了问卷调查,以5分制评估患者满意度.此外,调查了机动骑行期间的不良事件。
结果：总体满意度显示，51名患者中有44名（86％）将该水平评为3或更高。基于疾病原因或EQ-5D-5L指数的满意度水平没有显着差异。在满意度为2-3的19例患者中，术后患者和疼痛患者的比例趋于更高（p<0.05）。尽管51名患者中有26名（51％）报告说在出行过程中感到不安全，没有实际的不良事件，比如碰撞，被观察到。
结论：一项针对肌肉骨骼疾病患者使用无人驾驶交通的院内自主交通服务表现出了较高的满意度，并且是安全的，没有观察到严重的不良事件。自主移动部署的扩展有望实现移动作为医疗服务。
方法：从2022年1月至2月，51例出现步态障碍的肌肉骨骼疾病患者被纳入本研究。在门诊咨询后，从骨科门诊接待处到付款柜台的直线距离为100m，进行了无人驾驶出行。我们使用EQ-5D-5L指数评估生活质量，并在骑行活动前使用VAS评分评估疼痛，以调查患者的病情。骑行之后,我们进行了问卷调查,以5分制评估患者满意度.此外,调查了机动骑行期间的不良事件。
结果：总体满意度显示，51名患者中有44名（86％）将该水平评为3或更高。基于疾病原因或EQ-5D-5L指数的满意度水平没有显着差异。在满意度为2-3的19例患者中，术后患者和疼痛患者的比例趋于更高（p<0.05）。尽管51名患者中有26名（51％）报告说在出行过程中感到不安全，没有实际的不良事件，比如碰撞，被观察到。
结论：一项针对肌肉骨骼疾病患者使用无人驾驶交通的院内自主交通服务表现出了较高的满意度，并且是安全的，没有观察到严重的不良事件。自主移动部署的扩展有望实现移动作为医疗服务。
